{
    "Trade/Device Name(s)": [
        "ONLINE TDM Vancomycin"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K060586",
    "Predicate Device Reference 510(k) Number(s)": [
        "K954992"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LEH"
    ],
    "Summary Letter Date": "May 11, 2006",
    "Summary Letter Received Date": "March 7, 2006",
    "Submission Date": "March 6, 2006",
    "Regulation Number(s)": [
        "21CFR862.3950"
    ],
    "Regulation Name(s)": [
        "Vancomycin test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche Hitachi 911",
        "Roche Hitachi 912",
        "Roche Hitachi 917",
        "Roche Modular P analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay",
        "Spectrophotometry"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Roche ONLINE TDM Vancomycin homogeneous enzyme immunoassay for vancomycin measurement in serum or plasma.",
    "Indications for Use Summary": "Quantitative determination of vancomycin in human serum or plasma on Roche automated analyzers for diagnosis, treatment of overdose, and monitoring therapeutic levels.",
    "fda_folder": "Toxicology"
}